ArticleCancer medicine2021

A mixed-methods study of cyclin-dependent kinase 4 and 6 inhibitor symptom burden and quality of life among metastatic breast cancer patients and providers.

Laura B Oswald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.